Tag:

Joe Jimenez

Latest Headlines

Latest Headlines

Multibillion-dollar R&D strategy is paying off for Novartis

Novartis CEO Joe Jimenez managed to impress the Wall Street crowd today with some solid numbers for the second quarter.

Novartis blueprints $550M Swiss drug plant after layoffs backlash

Novartis CEO Joe Jimenez has a new answer to his critics in Switzerland, where the drug giant's major layoff plans ignited a wave of protests against the company.

Novartis CEO explains how and why he cut jobs

Novartis CEO Joe Jimenez says he chose to cut jobs "from a position of strength," rather than wait until company performance forced his hand.

Novartis chief touts new effort to offer streamlined, consumer-friendly trials

If there's one thing that Novartis ($NVS) CEO Joe Jimenez likes to talk about, it's efficiency.

Novartis CEO calls external focus key to fast-changing pharma

The idea of facing generic competition for a $5 billion blockbuster like Diovan would daunt almost any CEO. But Joe Jimenez (photo) says his experience hawking baby food and ketchup at Heinz made him

Jimenez counts on 7 drugs to take Novartis past Diovan

Maybe it's the rarefied Davos air or the long-range mountain views, but Novartis ($NVS) CEO Joe Jimenez is feeling optimistic about the post- Diovan future. After the Swiss drugmaker loses patent...

Novartis hammers out deal to keep Nyon plant open

Don't accuse Novartis ($NVS) CEO Joe Jimenez (photo) of refusing to listen. After workers in Nyon, Switzerland, stopped work to protest their plant's closure, the company sat down to talk about other

Jimenez offers bouquet to FDA's Hamburg

Novartis ($NVS) CEO Joe Jimenez (photo) is no stranger to the executive Q&A; he's been chatted up by almost every big media outlet there is. However, every once in a while, he drops a bit of new

Novartis workers end strike, but vow to fight on

The good news for Novartis ($NVS): Workers in Nyon, Switzerland, have ended their strike. The not-so-good: If union leaders and employees think the drugmaker isn't negotiating in good faith, they'll

Novartis staffers stop work at Nyon plant in jobs protest

Swiss workers haven't taken Novartis' ($NVS) job-cutting plans lying down. First, union members and political activists joined protests in Basel--including one at Chairman Daniel Vasella's (photo)